'My husband died suddenly, leaving me with three kids – but I'm turning things around now'
When you buy through links on our articles, Future and its syndication partners may earn a commission.
'I was sitting in my dining room, and I just started crying – I couldn't stop the tears,' begins Lucy Melville, 56. 'The grief that had built up over the previous 15 months came pouring out in one evening.
'My husband had died a little over a year before, I had lost my job, my three kids had all moved out of the house, and to top it all off, I was perimenopausal. I felt I was becoming invisible, shrivelling up, and that the world was telling me my time was up.
'I sat there, snot oozing out of my throat and nose, and briefly wondered how many paracetamol tablets it would take to stop all of this. This wasn't the life I had planned – a life without Brian and without my work family.
'We'd been married for just over 25 years when Brian was told he had stage four small cell carcinoma in May 2024. It had established itself in his lung and metastasized into his liver.
"Doctors said it was inoperable – that he was facing a terminal diagnosis. Soon after, he was given weeks, possibly only days to live.
'Not even six weeks after initially visiting the doctor, Brian died. My son called to tell me the news whilst I was out of the house searching for pain relief for him.
"I knew it was my responsibility to take care of our kids. I went into control mode – planning his funeral and doing his probate."
'After he died, I only took one week off work. I was a global publishing director at the time, having worked for the same company for 14 years. I threw myself into work, delaying my grief, pretending my world wasn't falling apart.
'Because Brian's life insurance policy had just matured out, I only had my salary after his death, and the sudden sole responsibility for putting three kids through college on my own.
'When I was informed of my redundancy in August 2024, I felt betrayed. I was signed off work and had my salary deducted for a brief period. I had worked so hard for that company, and it had formed part of my identity – an identity that was now gone.
"How was I meant to provide for myself and my college-age children without a job?"
'At the same time, I was experiencing perimenopause. Aside from the physical symptoms, menopause made me feel I was becoming redundant as a woman too. All the tropes about growing old felt true.
'To top it all off – the death of my husband, the evidence of ageing, and the loss of my job – I had become an empty nester, no longer extensively needed for my children's daily needs, and not enjoying the period of life my husband and I had planned together. I had never felt so isolated.
'That evening in my dining room, as I cried uncontrollably, a friend called me. I told her I couldn't do this anymore. She phoned one of my daughters out of concern, asking if someone could come to visit me. Another friend came to my door, and silently she entered and just held me."
'It was this evening in October 2024 – my lowest point – when I knew I had to do something to turn things around, and the spark lit again.
'The next day, I started networking on LinkedIn with publishing contacts to find work as a consultant.
"I found consultancy work, and was invited to a meeting with a client to set up my own publishing company with them because of my vast experience. When I said I couldn't put up the investment, the client offered to invest in me. I've now co-founded my own publishing company, River Light Press, with these wonderful business partners.
'For someone to say, in the depths of my despair, that they believed in me felt so affirming.
'I started paying for grief therapy, too. Although extraordinarily expensive, it was money well spent. My therapist saw such a huge transformation after a few months that she eventually suggested we conclude our regular meetings.
'In the last 18 months, I've pursued my love of acting and poetry. I've landed a part in The Importance of Being Earnest at my local playhouse in Oxford, read my poetry – which touches on grief and loss with a bit of humor – in front of crowds at a local venue, and sung in some concerts."
'All of this living has been done with Brian in mind. Right before he died, he told me I would go on to live, to be loved, and to love again.
"I want to go on living, because he can't. He didn't have a choice.
"I owe it to him, my kids, and myself to live the best possible life – to be fulfilled."

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Heat health alert extended as soaring temperatures set to stay
A heat health alert has been extended as sizzling temperatures continue to impact Sussex. The UK Health Security Agency has extended the amber heat health alert until Wednesday, July 2, at 9am. It was originally due to end tomorrow, July 1. The alert warns of significant impacts across health and social care services, including a rise in deaths among those aged 65 and over or with health conditions. There may also be impacts on younger age groups. There is also likely to be an increased demand on all health and social care services. READ MORE: Updates as Sussex braces itself for another day of hot weather Temperatures are set to remain high in Brighton, with an average of 28C tomorrow and 27C on Wednesday. The weather for the rest of the week is forecast to remain warm, with temperatures sitting at around 23 to 24C until Sunday, July 6. The UKHSA advises people to keep out of the sun at the hottest time of the day, between 11am and 3pm, and check on family, friends and neighbours who may be at higher risk of becoming unwell.
Yahoo
an hour ago
- Yahoo
Controversial project could create human DNA from scratch
A controversial project that aims to create the building blocks of human life has started. It was previously thought creating human DNA could lead to designer babies or unforeseen complications and changes for future generations. However, in a world first, medical charity the Wellcome Trust, has given an initial £10m to start the project. Scientists say it has the potential to transform the understanding of human health, open opportunities to develop treatments for incurable diseases and develop climate-resistant crops. 'Our DNA determines who we are and how our bodies work,' said Michael Dunn, director of discovery research at Wellcome. 'Through creating the necessary tools and methods to synthesise a human genome, we will answer questions about our health and disease that we cannot even anticipate yet, in turn transforming our understanding of life and wellbeing.' In the next five to ten years scientists aim to build a full synthetic human chromosome. Every cell in the human body contains DNA, which is a molecule that carries genetic information that physically makes people who they are. The new Synthetic Human Genome Project will potentially allow researchers not just to be able to read DNA but create parts of it. Scientists will first aim to create larger blocks of human DNA to try to create a synthetically constructed a human chromosome – which contains genes that govern our development, repair and maintenance. These chromosomes would then be studied to find out how genes and DNA regulate our bodies. The project is led by Professor Jason Chin from the Generative Biology Institute at Ellison Institute of Technology and the University of Oxford, in collaboration with team of researchers from Cambridge, Kent, Manchester, Oxford and Imperial College London. 'The ability to synthesize large genomes, including genomes for human cells, may transform our understanding of genome biology and profoundly alter the horizons of biotechnology and medicine,' said Professor Chin. The project will be confined to test tubes and petri dishes, with no attempt to create synthetic life. But critics fear the research opens the way for researchers to create enhanced or modified humans. Professor Bill Earnshaw, a genetic scientist at Edinburgh University who designed a method for creating artificial human chromosomes fears this research could open the opportunity to attempt to create biological weapons, enhanced humans or even creatures that have human DNA. "The genie is out of the bottle," he told BBC News. "We could have a set of restrictions now, but if an organisation who has access to appropriate machinery decided to start synthesising anything, I don't think we could stop them." There will also be a dedicated social science project running alongside the researchers led by Professor Joy Zhang, a sociologist, at the University of Kent. "We want to get the views of experts, social scientists and especially the public about how they relate to the technology and how it can be beneficial to them and importantly what questions and concerns they have," she said.


Medscape
an hour ago
- Medscape
Plant Extracts Show Promise in Hand Osteoarthritis Relief
TOPLINE: In patients with symptomatic hand osteoarthritis (OA) who took two tablets daily containing a combination of patented plant extracts of Curcuma longa and Boswellia serrata, a significant reduction in pain was observed compared with that in those who took placebo over 3 months, with a favourable safety profile. METHODOLOGY: Researchers conducted a double-blind, randomised controlled trial across 11 centres in Belgium (2022-2024) to evaluate the efficacy and safety of the combination of plant extracts in hand OA. They included 162 adults with symptomatic hand OA (mean age, 63.1 years; 76.5% women) who reported hand pain on ≥ 50% of days in the prior month and ≥ 48 hours before baseline, with pain ranging from 40 to 80 mm on a 100-mm visual analog scale (VAS) in at least one hand over the last 24 hours. The patients were randomly assigned to receive two identical looking tablets of either the combination of plant extracts (n = 83) or placebo (n = 79) daily for 3 months. The primary outcome was the mean change in finger pain on both hands during the past 24 hours on the VAS over 3 months. Several secondary outcomes evaluated at months 1 and 3 included pain on the VAS, number of painful and swollen joints, patient global assessment, and quality of life. Safety outcomes were assessed throughout the study. TAKEAWAY: At month 3, patients who received the plant extracts had a greater mean VAS pain reduction of 24.7 mm compared with 16.2 mm in those who received placebo (difference, -8.5 mm; P = .03); similar benefit was observed at month 1 (difference, -7.0 mm; P = .04). Patients receiving the plant extracts vs placebo showed significant improvements in the patient global assessment (difference, -9.6 mm; P = .01) and quality of life score (P = .01) at month 3. Mean global compliance was more than 90% in both groups, with no significant difference. The number of adverse effects did not differ significantly between the two groups, and most of them were unrelated to the use of plant extracts. IN PRACTICE: "The investigational product used in the study is an option for healthcare providers and researchers working on novel pain relief products," the authors wrote. SOURCE: This study was led by Yves Henrotin, Princess Paola Hospital and University of Liège, Liège, Belgium. It was published online on June 17, 2025, in Osteoarthritis and Cartilage. LIMITATIONS: The authors excluded the evaluation of short-term pain to confirm the rapid action of the combination of plant extracts. Imaging outcomes including x-ray or ultrasound were missing, which prevented the assessment of inflammation or bone erosion. Multiple secondary endpoints may have affected the statistical interpretation, with increased odds of obtaining the significant results. DISCLOSURES: This study received funding from Tilman SA. Two authors reported receiving speaker fees from the funding agency. REFERENCES: Henrotin Y, de Schrijver F, De Vlam K, et al. Effect of a combination of C. longa and B. serrata extracts on hand osteoarthritis. Results of a double-blind, randomised, placebo-controlled, multicenter trial. Osteoarthr Cartil. Published online June 17, 2025. doi:10.1016/ This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.